agilon health Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, agilon health stock has a consensus rating of "Hold" and an average price target of $60.36. The average 1-year stock price forecast is 49.38% lower than the current stock price, while the lowest is $22 (-81.55%) and the highest is $95 (-20.34%).

Price Target: $60.36 (-49.38%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$22	$60.36	$61	$95
Change	-81.55%	-49.38%	-48.85%	-20.34%

Analyst Ratings

The average analyst rating for agilon health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	4	4
Buy	0	0	0	0	0	0
Hold	13	13	13	13	11	11
Sell	2	2	2	2	2	2
Strong Sell	0	0	0	0	0	0
Total	17	17	17	17	17	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lance Wilkes Bernstein	Bernstein	Hold Maintains $86	Hold	Maintains	$86	-27.88%	Jun 9, 2026
Andrew Mok CFA Barclays	Barclays	Hold Upgrades $0.5 → $81	Hold	Upgrades	$0.5 → $81	-32.08%	May 26, 2026
Bill Sutherland Benchmark Co.	Benchmark Co.	Buy Maintains $13 → $95	Buy	Maintains	$13 → $95	-20.34%	May 21, 2026
Jailendra Singh Truist Financial	Truist Financial	Hold Reiterates $67	Hold	Reiterates	$67	-43.82%	May 18, 2026
Daniel Grosslight Citi	Citi	Hold Maintains $19 → $80	Hold	Maintains	$19 → $80	-32.91%	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

5.72B

from 5.93B

-3.60%

from 5.93B

Revenue Next Year

6.08B

from 5.72B

6.30%

from 5.72B

EPS This Year

-2.42

from -21.86

EPS Next Year

-0.62

from -2.42

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.52B	2.39B	4.32B	6.06B	5.93B	5.72B
Revenue Growth	24.88%	56.97%	80.74%	40.41%	-2.11%	-3.60%
Gross Profit	65.74M	111.36M	69.67M	4.84M	-160.02M	146.79M
Gross Margin	4.32%	4.66%	1.61%	0.08%	-2.70%	2.57%
Operating Income	-366.84M	-102.91M	-231.95M	-283.96M	-421.08M	-111.70M
Net Income	-406.49M	-106.55M	-262.60M	-260.15M	-391.35M	-50.16M
EPS	-	-	-	-	-21.86	-2.42
Free Cash Flow	4.09M	-131.38M	-64.40M	-35.88M	-81.23M	-83.59M
No. Analysts	-	-	-	-	-	16

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	5.8B
Avg	5.7B
Low	5.6B

Revenue Growth

Revenue Growth	2026	2027	2028
High	-2.3%
Avg	-3.6%
Low	-6.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.43
Avg	-2.42
Low	-4.81

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-